services
Oral Solid dose
Drug Product
Oral solid dose (OSD) drug product manufacturing has long been a core capability of Avara, and we continue to invest in specialized equipment and flexible capacity to support projects across a range of product types and classifications.
We offer clinical and commercial-scale manufacturing of OSD drug product, including potent compounds and targeted release formulations, from facilities with a long history of serving global pharma supply chains.
In line with our commitment to invest in industry best practices, Avara has expanded our OSD capabilities to include DEA licensing for Schedule II to V controlled drugs, hot melt technology, tri-layer tablets and increased encapsulation capacity.
OSD Manufacturing
- Blending
- Milling
- Dry granulation
- Wet granulation
- Extrusion
- Spheronization
- Hot melt technology
- Spray drying
- Fluid bed drying
- Encapsulation
- Compression (including bi- / tri-layer)
- Film coating
- Column coating
- Wurster coating
- Printing
- Tablet visual inspection
- Potent compounds
- DEA Controlled Drugs (II-V)
- Comprehensive laboratory support
FACILITIES
AIKEN
South Carolina, USA
- Oral Solid Dose
- OTC Product Portfolio
- Multiple Rx-To-OTC Switches
- Specialty Packaging
- Former GSK facility
ARECIBO
Puerto Rico
- Oral Solid Dose
- Advanced Technologies
- DEA Controlled Drug II-V
- Highly Potent Products
- High-Speed Bottling
- Former Merck facility
NORMAN
Oklahoma, USA
- Oral Solid Dose
- Clinical-Commercial Scale
- Potent Products
- High Resolution Inspection
- Avara’s Corporate Headquarters
- Former Astellas facility
Packaging
Each of our sites provide integrated packaging for the dosage forms they manufacture, including primary and secondary packaging services, automated inspection, specialty packaging, and serialization to international requirements.
Integrated Packaging,
Automated Inspection
Sterile FIll-FInish
We offer liquid and lyophilized fill-finish of sterile injectable products, including terminal sterilization and high containment capabilities for potent compounds.
Global Reach To 40+ Countries
